The U.S. government’s recent $2 billion investment in quantum computing raises legal questions regarding its funding sources and intended use.
The U.S. government recently announced a significant $2 billion investment across nine quantum computing companies, a move aimed at bolstering the domestic supply chain and countering China’s influence in critical technology sectors. This initiative includes a new venture from IBM.
However, the legality of these investments has come under scrutiny. Representative Zoe Lofgren (D–Calif.), the ranking member of the House Science, Space, and Technology Committee, has raised concerns that these deals may not comply with congressional appropriations. She argues that the funds were originally allocated to support public research in semiconductors, not quantum computing.
Lofgren stated, “This announcement is illegal and troubling on so many levels,” highlighting that the funding originates from the CHIPS and Science Act, which was enacted during the Biden administration. This legislation specifically earmarked resources for microelectronics research and development, with a focus on semiconductor technology.
According to Lofgren, the technology associated with quantum computing only partially overlaps with semiconductor technology. She emphasized that the funds were intended to foster public-private research partnerships, which she believes these deals do not represent. Furthermore, she pointed out that a substantial portion of the investment is directed toward IBM, raising concerns about potential conflicts of interest involving Dario Gil, a former IBM executive who currently serves as the Under Secretary for Science at the Department of Energy.
Despite her criticisms, Lofgren clarified that her objections do not imply that quantum processing technology is a poor investment or that the companies involved lack merit. Instead, she insists that any support for these companies should come through a proper congressional allocation of funds.
As the situation stands, it remains unclear how the investment can be halted. While a lawsuit has been suggested as a potential remedy, it would require a party willing to take legal action. A company that could have benefited from the original allocation for semiconductor research might argue that it has been adversely affected by the diversion of funds to quantum computing. However, such legal proceedings could take considerable time, potentially allowing the funds to be fully expended before a resolution is reached.
The U.S. Department of Commerce announced the investment on Thursday, detailing the distribution of funds. IBM is set to receive $1 billion to establish a new company focused on manufacturing chips for quantum computers. Additionally, contract chipmaker GlobalFoundries will receive $375 million to construct a domestic factory capable of producing components for various types of quantum machines.
Other recipients include D-Wave, Rigetti Computing, and Infleqtion, each receiving $100 million, while Diraq is allocated up to $38 million to address key technical challenges that have hindered the advancement of more powerful quantum computers, according to the Commerce Department.
The ongoing debate surrounding this investment underscores the complexities of federal funding and the legal frameworks governing technological advancements. As the U.S. seeks to maintain its competitive edge in quantum computing, the implications of this funding decision will likely continue to unfold in the coming months.
For further details, refer to The American Bazaar.